New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future

Viewpoint: Challenges and Opportunities in Tuberculosis Research

(2012) P. S. Kim et al.   JOURNAL OF INFECTIOUS DISEASES

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

(2012) Patrick P. J. Phillips et al.   JOURNAL OF INFECTIOUS DISEASES

Tuberculosis Drug Development

(2011) Anne F. Luetkemeyer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Integration of Antiretroviral Therapy with Tuberculosis Treatment

(2011) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Development of Novel Combination Therapies

(2011) Janet Woodcock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection

(2011) Timothy R. Sterling et al.   NEW ENGLAND JOURNAL OF MEDICINE

Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis

(2011) François-Xavier Blanc et al.   NEW ENGLAND JOURNAL OF MEDICINE

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis

(2011) Diane V. Havlir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Global tuberculosis drug development pipeline: the need and the reality

(2010) Zhenkun Ma et al.   LANCET

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

(2010) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis

(2009) Susan E. Dorman et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects

(2009) A. M. Ginsberg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Isoniazid Plasma Concentrations in a Cohort of South African Children with Tuberculosis: Implications for International Pediatric Dosing Guidelines

(2009) Helen McIlleron et al.   CLINICAL INFECTIOUS DISEASES

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

(2009) Marcus B Conde et al.   LANCET

The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis

(2009) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model

(2008) K. N. Williams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)

(2008) Andrew J. Nunn et al.   TUBERCULOSIS

Developing new drugs for the treatment of drug-resistant tuberculosis: a regulatory perspective

(2008) Leonard V. Sacks et al.   TUBERCULOSIS

Ensuring the Involvement of Children in the Evaluation of New Tuberculosis Treatment Regimens

(2008) William J Burman et al.   PLOS MEDICINE